21 July 2023 in Thoracic Research and Practice
Austrian syndrome corresponds to the triad of meningitis, pneumonia, and endocarditis caused by Streptococcus pneumoniae, there is no global or local incidence given the infrequency of entity. Scarce cases are published in Latin America, with none of them in Colombia. A case of Austrian syndrome by penicillin-resistant S. pneumoniae in an immunocompetent patient is presented. Aortic valve is the most frequent site involved in Austrian syndrome; this patient had an unusual localization of the vegetation on the right coronary artery ostium. The prognosis is poor with a mortality rate of 30% or higher, this patient survived despite systemic complications. Vaccination status impacts in prevention and severity of cases because responsible serotypes are often included in available vaccines. The patient had a serotype covered by available vaccines; however, her vaccination status was unknown. Thus, we present the first case reported in Colombia of Austrian syndrome by a penicillin-resistant S. pneumoniae, in a patient with no identified comorbidities or toxicological history, with a successful evolution.
23 January 2026 in Current Fungal Infection Reports
Purpose of Review: This review aims to synthesize current evidence on Neoscytalidium dimidiatum onychomycosis, an emerging non-dermatophyte infection that increasingly challenges diagnostic accuracy and therapeutic success. We seek to clarify its taxonomic characteristics, clinical presentation, epidemiology, and resistance patterns, addressing how clinicians can better identify and manage this difficult-to-treat pathogen. Recent Findings: Neoscytalidium dimidiatum has increasingly been acknowledged as a cause of onychomycosis and superficial dermatomycoses, particularly in tropical and subtropical areas. Its dual synanamorphs and rapid growth yield darkly pigmented colonies and mixed hyaline dematiaceous hyphae. Clinically, it mimics dermatophyte onychomycosis but often shows gray-black discoloration, multinail involvement, and marked resistance to standard antifungals. Summary: Current evidence indicates that N. dimidiatum represents a growing global threat due to environmental exposure and inherent antifungal resistance. Accurate recognition, mycological confirmation, and tailored combination therapy are essential to improving outcomes.